Companies like Krispy Kreme, Darden and Fogo de Chao have seen little change in frequency from these guests, and Circana data ...
Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...
As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly ...
As GLP-1 medications reshape eating habits and private label innovation booms, beverages must deliver nutrient density, low sugar and smart positioning to stay competitive, according to Ravi Jhala, VP ...
Jacksonville Journal-Courier on MSN
Food companies are targeting users of weight-loss drugs with 'GLP-1 friendly' labels
Meals and snacks with "GLP-1 Friendly" labels on the packaging are becoming more common as a growing number of Americans try ...
Everyday Health on MSN
Using GLP-1s for Obesity During Menopause: Benefits and Risks
Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide and liraglutide mimic endogenous incretin signals to stimulate glucose-dependent insulin release, thereby suppressing glucagon, ...
Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...
In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...
The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.
Discover the top five ingredient trends driving GLP-1 innovation in the food and beverage industry. From proteins and fibers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results